Mylan gets OK for generic Femara
PITTSBURGH — Mylan has launched a generic treatment for breast cancer, the drug maker said Monday.
Mylan announced the launch of letrozole tablets in the 2.5-mg strength, an adjuvant treatment for postmenopausal women with hormone receptor-positive early-stage breast cancer.
The drug is the first generic version of Novartis’ Femara, which had sales of about $682 million in 2010, according to IMS Health.
Menactra approved for use in infants, toddlers
SILVER SPRING, Md. — The Food and Drug Administration has approved the first vaccine for preventing meningococcal disease in children as young as 9 months old, the agency said.
The FDA announced the approval of Menactra, made by Sanofi Pasteur, the vaccines arm of French drug maker Sanofi-Aventis. Meningococcal disease is a life-threatening illness caused by Neisseria meningitidis bacteria that infect the bloodstream and the lining surrounding the brain and spinal cord.
Between 10% and 15% of people who develop meningococcal disease die from the infection, even with appropriate antibiotics and intensive care, while another 10% to 20% suffer such complications as brain damage, loss of limbs and hearing loss.
Menactra already had FDA approval for patients ages 2 to 55 years.
Walgreens collects more than 15,000 lbs. of unused, expired medications
HOUSTON — Walgreens’ Safe Medication Disposal Program, launched in September 2010 in partnership with Sharps Compliance, has collected more than 15,000 lbs. of unused or expired medications, Walgreens announced Monday.
“We estimate that more than 200 million lbs. of unused dispensed medications are disposed of improperly each year,” Sharps Compliance president and CEO David Tusa said.
“We are encouraged that many of our patients have taken advantage of this medication disposal opportunity,” stated Richard Ashworth, Walgreens VP pharmacy operations. “In addition to the environmental benefits, it addresses a common safety concern in communities. Customers are pleased to have a solution that allows them to be environmentally responsible and keep medications out of unintended hands with convenience and ease.”
As part of the program, U.S. Postal Service-approved envelopes are available at Walgreens for $3.99 for customers to place, seal and mail prescription or over-the-counter medications they no longer use to a facility for proper treatment. Controlled substances are excluded from this program due to current regulations. Postage is included in the cost of the envelope.